Cambridge Investment Research Advisors’s AbCellera Biologics ABCL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-15,705
| Closed | -$41K | – | 3461 |
|
|
2024
Q3 | $41K | Sell |
15,705
-8,463
| -35% | -$22.1K | ﹤0.01% | 3343 |
|
|
2024
Q2 | $72K | Sell |
24,168
-6,637
| -22% | -$19.8K | ﹤0.01% | 3190 |
|
|
2024
Q1 | $140K | Sell |
30,805
-821
| -3% | -$3.73K | ﹤0.01% | 3101 |
|
|
2023
Q4 | $181K | Sell |
31,626
-2,709
| -8% | -$15.5K | ﹤0.01% | 2933 |
|
|
2023
Q3 | $158K | Sell |
34,335
-408
| -1% | -$1.88K | ﹤0.01% | 2882 |
|
|
2023
Q2 | $224K | Sell |
34,743
-1,675
| -5% | -$10.8K | ﹤0.01% | 2782 |
|
|
2023
Q1 | $275K | Sell |
36,418
-6,800
| -16% | -$51.3K | ﹤0.01% | 2561 |
|
|
2022
Q4 | $438K | Sell |
43,218
-1,954
| -4% | -$19.8K | ﹤0.01% | 2118 |
|
|
2022
Q3 | $447K | Buy |
45,172
+1,565
| +4% | +$15.5K | ﹤0.01% | 2028 |
|
|
2022
Q2 | $464K | Sell |
43,607
-3,361
| -7% | -$35.8K | ﹤0.01% | 2013 |
|
|
2022
Q1 | $458K | Buy |
46,968
+1,205
| +3% | +$11.8K | ﹤0.01% | 2182 |
|
|
2021
Q4 | $654K | Buy |
45,763
+3,355
| +8% | +$47.9K | ﹤0.01% | 1891 |
|
|
2021
Q3 | $850K | Buy |
42,408
+15,526
| +58% | +$311K | ﹤0.01% | 1655 |
|
|
2021
Q2 | $591K | Buy |
+26,882
| New | +$591K | ﹤0.01% | 1923 |
|